Roche Holding AG (OTCMKTS:RHHBY) Receives Consensus Recommendation of “Hold” from Brokerages

Roche Holding AG (OTCMKTS:RHHBY) has been given a consensus rating of “Hold” by the eleven research firms that are covering the firm, MarketBeat Ratings reports. One investment analyst has rated the stock with a sell rating, six have assigned a hold rating and four have issued a buy rating on the company. The average 12 month price objective among brokerages that have issued ratings on the stock in the last year is $51.50.

A number of research firms have weighed in on RHHBY. Morgan Stanley upgraded shares of Roche from an “underweight” rating to an “equal weight” rating and set a $46.00 price objective for the company in a research note on Friday, April 24th. Zacks Research downgraded shares of Roche from a “hold” rating to a “strong sell” rating in a research note on Tuesday, July 14th. Finally, HSBC cut shares of Roche from a “buy” rating to a “hold” rating in a report on Monday, July 6th.

Institutional Trading of Roche

Large investors have recently modified their holdings of the company. McIlrath & Eck LLC bought a new position in Roche in the first quarter worth approximately $39,000. Oakworth Capital Inc. increased its stake in shares of Roche by 20.8% in the 4th quarter. Oakworth Capital Inc. now owns 1,658 shares of the company’s stock worth $86,000 after purchasing an additional 285 shares in the last quarter. Atlas Capital Advisors Inc. purchased a new stake in shares of Roche in the 4th quarter worth $192,000. Pinnacle Wealth Management Advisory Group LLC bought a new position in Roche in the 1st quarter worth $208,000. Finally, Enterprise Financial Services Corp raised its holdings in Roche by 6.6% in the 1st quarter. Enterprise Financial Services Corp now owns 5,576 shares of the company’s stock worth $277,000 after purchasing an additional 345 shares during the period.

Roche Price Performance

Shares of OTCMKTS RHHBY opened at $56.41 on Thursday. Roche has a 1 year low of $37.51 and a 1 year high of $60.85. The firm has a 50-day moving average of $51.95 and a 200 day moving average of $52.84. The company has a debt-to-equity ratio of 0.72, a current ratio of 1.38 and a quick ratio of 1.12.

Roche Company Profile

Roche Holding AG is a Swiss multinational healthcare company headquartered in Basel, founded in 1896 by Fritz Hoffmann‑La Roche. The company operates primarily through two complementary divisions — Pharmaceuticals and Diagnostics — and is known for integrating drug development with diagnostic capabilities to advance personalized healthcare. In the United States and other international markets, shares trade as American Depositary Receipts under the ticker RHHBY (OTCMKTS:RHHBY).

In pharmaceuticals, Roche focuses on developing and commercializing prescription medicines across therapeutic areas including oncology, immunology, infectious diseases and neuroscience, with a notable emphasis on targeted biologics and personalized therapies.